- Science Integration
- Basic Careers
- Cellular, Developmental and Physiological Sciences
- Genetic and Molecular Sciences
- Neuroscience and Mental Health
- Infection and Immuno-biology
Kevin Moses joined the Trust in July 2011. Kevin was the founding Chief Academic Officer at the Howard Hughes Medical Institute's Janelia Farm Research Campus. Previously, he held faculty positions at Emory University and the University of Southern California, where he led a research group that studied morphogenetic mechanisms in the development of the Drosophila compound eye.
Executive Projects Manager
Ellie Estchild joined the Trust in 2014 and works for Kevin Moses within the Science Directorate. She has a first degree in Microbiology and Genetics from University College London and an MSc in Public Health from the London School of Hygiene and Tropical Medicine. Previous positions include Tropical Epidemiology Group Coordinator at the London School of Hygiene and Tropical Medicine and Grants Manager at the Academy of Medical Sciences. At the Trust, Ellie delivers a portfolio of work for the Director of Science, provides administrative support and manages the annual series of Researcher Meetings for the Science Division.
Head of Operations, Science Division
Anna Curson joined the Trust in 1999 and is now Head of Operations providing strategic leadership to the delivery of operational and communications activities across the Science Division. Anna has BSc in Chemistry with German from the University of Sussex and an MSC in Science and Technology Policy from the Science and Technology Research Unit. Prior to joining the Trust Anna worked as a project development consultant in the engineering sector. In addition to her role as Head of Operations, Anna is project leader for the Diamond synchrotron project, managing a cross-Trust team to represent the Trust’s interest in this project.
Senior Operations Officer
Sophie Drinkwater joined the Trust in 2010 and now works within the Science division on various operational and communications activities. Soph has a BSc in Biology with French from the University of Sussex and an MSc in Science Communication from the University of the West of England.Soph also coordinates the Trust’s Strategic Awards Committee.
Project Support Officer
Rebecca O’Brien joined the Trust in 2014 and contributes to the operational and communication activities in the division. Rebecca has a BSc in Biological Sciences from the University of Southampton and an MSc in Ecology, Evolution and Conservation from Imperial College London. Previously, she worked as a senior publishing assistant at Nature Publishing Group and as a project co-ordinator in Mongolia, Thailand and the Philippines.
Head of Science Integration - Structures
Chonnettia Jones has over ten years of academic research experience ranging from microbiology to genetics to cellular and developmental biology. Following her PhD, she continued her studies in genetics and developmental neurobiology as a postdoctoral research fellow at Emory University. She also has experience as an Instructor teaching graduate-level science courses at Emory University and the University of Georgia. Before joining the Wellcome Trust, Chonnettia managed a collaborative research programme at the Janelia Farm Research Campus of the Howard Hughes Medical Institute. Chonnettia joined the Trust in 2012 working collaboratively across the Science Division to set up frameworks and tools for the management, oversight and coordination of key scientific activities in the division.
Science Portfolio Advisers
Peter O’Donovan received his BSc in Biochemistry from University College Cork, Ireland, after which he undertook his PhD with Cancer Research UK, working on DNA damage mechanisms and their role in skin carcinogenesis in organ transplant recipients. Peter then moved to the Dana Farber Cancer Institute at Harvard Medical School in Boston for a postdoctoral fellowship, studying how chromatin state affects DNA double-strand break repair. Prior to joining the Wellcome Trust in November 2014, Peter acted as an Executive Editor with BioMed Central. Peter is a Science Portfolio Advisor in the Science Integration Structures department where he works on the management, oversight and coordination of key scientific activities across the Science division
Matthew Thakur took an MSci in Neuroscience at the University of Nottingham, then spent time in industry at Merck before studying the neurobiology of pain for a PhD from University College London. His postdoctoral work examined interactions between the immune and nervous system at King's College London. Having joined the Trust in 2015, Matt works in the Integration, Structures team to support and coordinate cross-cutting initiatives, including the Seed Awards.
Candy Hassall leads the Wellcome Trust's funding activities in the area of basic biomedical research training and careers. These provide a range of opportunities for support: from Vacation Scholarships for undergraduates through to Principal Research Fellowships for outstanding, internationally recognised senior scientists and also the Investigator Award scheme. As part of this role, Candy works closely with those funded by the Wellcome Trust, as well as other stakeholders. She held a British Heart Foundation Basic Science Lectureship at University College London before joining the Trust in 1996.
Shewly Choudhury as the Basic Careers Portfolio Adviser, is responsible for contributing to the development and implementation of the Wellcome Trust’s strategy and policy on basic (non-clinical) research career schemes in the UK, ensuring delivery against the strategic aims of the Trust. She also supports the Head of Basic Careers in managing the Trust’s extensive portfolio in this area. Since joining the Wellcome Trust in October 2005, Shewly has held a number of roles in Science Funding and worked (for a short time) in the Strategic Planning and Policy Unit. Shewly has a BSc (Hons) in biological sciences from the University of Leicester and undertook a PhD in neuroscience at the Babraham Institute at the University of Cambridge and GlaxoSmithKline.
Cellular, Developmental and Physiological Sciences
Alison Cave holds a degree in Pharmacology and a PhD in biochemistry, both from the University of London. Following her PhD, Alison completed postdoctoral training in Boston, USA and Guy’s Hospital in London before returning to King’s College London as a lecturer and subsequently senior lecturer. Her research interests initially focussed on the protection of the heart following ischaemia and reperfusion but later centred on the role of oxidant stress, in the development and progression of cardiac hypertrophy with a specific focus on the fibrosis which accompanies this pathology. She was also interested in the mechanisms underlying the cardiac dysfunction associated with sepsis.Prior to joining the Trust in 2013 she worked at the Medicines and Healthcare Products Regulatory Agency monitoring and assessing the safety of marketed medicines.
Senior Portfolio Developer
Sheny Chen has a BSc in Biology from Emory University and a PhD in Genetics and Developmental Biology from Columbia University. She completed her postdoctoral training at Columbia University and the University of Oxford where she worked on pattern formation in the fly and mammalian heart development, respectively. Sheny joined the Wellcome Trust in 2013.
Science Portfolio Advisers
Dev Churamani has a BSc and a MSc in Biomedical Sciences from King’s College London and a PhD in Cell Physiology from University College London. He continued his postdoctoral work at UCL in the Department of Cell and Developmental Biology where his research focused on a novel intracellular calcium-mobilising messenger involved in the release of calcium from acidic organelles. Prior to joining the Trust in 2013, he worked at the Food Standards Agency in the Division of Microbiological Food Safety, working on Foodborne Disease and Antimicrobial Resistance.
Danielle Cannon has a first BSc (Hons) in Physics from the University of Dundee and a PhD in BioPhysics, studying amyloid aggregation at the University of Cambridge. Her postdoctoral training in the College of Life Sciences at the University of Dundee and in the Laboratory of Molecular and Cell Biology at University College London focused on single cell heterogeneity of cell cycles and transcription factors in mouse stem cells and in model systems such as dictyostelium using quantitative time lapse imaging and custom in silico models. Danielle joined the Trust in 2015.
Michael Dunn is Head of the Genetic and Molecular Sciences team in Science Funding. Having obtained a PhD in biochemistry at the University of Cambridge, he went on to work on the genetics of type 1 diabetes at the Wellcome Trust Centre for Human Genetics in Oxford. Michael joined the Trust in 2000. His role is to manage and develop its scientific portfolio and community of investigators to enable the Trust to achieve its mission.
Senior Portfolio Developers
Audrey Duncanson joined the Wellcome Trust in 2000 and is now a Senior Portfolio Developer. Her role is to help develop and implement strategic funding initiatives in genetics, genomics and the molecular sciences, and to oversee the portfolio in these areas. After receiving a BSc (Hons) in molecular biology and a PhD from the Department of Genetics, University of Glasgow, Audrey went on to postdoctoral studies in fly neurodevelopment at the Department of Genetics, University of Leicester. Her current responsibilities include the Wellcome Trust Case Control Consortium, the UK10K sequencing project and H3 Africa.
Victoria King joined the Wellcome Trust in 2012 to help oversee the portfolio and develop and implement strategic funding initiatives in genetics and the molecular sciences. After a first degree and subsequent PhD in Biochemistry (Universities of Sussex and Sheffield) Victoria held research development roles in several medical research charities including Asthma UK, Breakthrough Breast Cancer and most recently Diabetes UK where she was Head of Research. Victoria has also spent time working for the NIHR Comprehensive Clinical Research Network to develop and implement strategies to support clinical research. Her current responsibilities at the Trust include development of the Trust’s research portfolio at the chemistry biology interface, the Human Induced Pluripotent Stem Cells Initiative (HIPSCI) and ELIXIR.
Tom Collins joined the Wellcome Trust’s Molecular and Physiological Sciences team in 2012 following postdoctoral research into the development and treatment of heart failure at the National Heart and Lung Institute. He has a first degree in physiology and holds a PhD from Oxford University, where his thesis focussed on novel signalling pathways in the healthy myocardium. At the Trust, his current responsibilities include the Structural Genomics Consortium, the International Mouse Phenotyping Consortium and the Molecular Basis of Cell Function expert review group.
John Isaac obtained a BSc in Pharmacology and Biochemistry and a PhD in Neuroscience at the University of Southampton. He completed postdocs at UCSF with Dr. Robert Malenka’s laboratory and at University of Bristol with Prof. Graham Collingridge.John then set up his own lab at University of Bristol in 1997, rising to rank of Professor. In 2004 John left Bristol to set up a lab at the Intramural Program at NINDS/NIH in Bethesda, USA and in 2010 returned to the UK to work for Eli Lilly and Company in Surrey, UK.In November 2014 John joined The Wellcome Trust as Head of Neuroscience and Mental Health.
Senior Portfolio Developer
Raliza Stoyanova joined the Neuroscience and Mental Health team in 2012 having previously trained in cognitive neuroscience at the MRC Cognition and Brain Sciences Unit, supported by the Gates Cambridge Trust. She also holds degrees from the University of Toronto and the University of the Witwatersrand. Her background includes behavioural and functional neuroimaging research in healthy volunteers and clinical populations as well as more clinically focussed work in the mental health sector.Her role at the Trust is to oversee the cognitive neuroscience and mental health portfolio , manage relationships with relevant stakeholders and assist in the development of strategic funding initiatives.
Science Portfolio Adviser
Daniel Lametti is a Science Portfolio Advisor with the neuroscience and mental health team at the Trust. He has a BSc in Physics from Bishop’s University and an MSc and PhD in Experimental Psychology from McGill University. His doctoral thesis and postdoctoral work examines how the brain learns to produce and perceive speech. At the Trust, Daniel overseas the neuroscience portfolio and helps identify funding opportunities that increase our understanding of the nervous system in health and disease.
Mike Turner has been Head of Infection and Immunobiology at The Wellcome Trust since January 2014. The remit of the department includes all infectious disease and immunology of biomedical and veterinary relevance. Before that he was at the University of Glasgow, UK where he held Beit and Royal Society Fellowships before becoming a member of staff; latterly as Professor of Parasitology. He was also at various times head of division, assistant director of faculty and deputy dean of graduate school. His research interests focussed on the cell biology, immunology, genetics, genomics and population biology of trypanosome parasites that cause African sleeping sickness in humans and Nagana in livestock. He has also worked on the genomics of malaria parasites and the immunoepidemiology of schistosomes.
Senior Portfolio Developers
Charlie Weller has over 15 years of research experience in both academic and pharmaceutical environments ranging from host pathogen interactions to cellular and molecular immunology. After completing a BSc in genetics at Birmingham University, and a PhD in Immunology at Imperial College London, Charlie continued her studies at Imperial as a postdoctoral fellow investigating mast cell localization and function. Before joining the Wellcome Trust, Charlie was a laboratory head at Novartis with a focus on target identification and validation within the respiratory disease area. Charlie joined the Wellcome Trust in 2014 as a Senior Portfolio Developer and will be overseeing the Immunology portfolio.
Science Portfolio Advisers
Michael Chew obtained his PhD in parasitology at Imperial College London. He contributes to the development and implementation of strategic funding activities and initiatives in the team. Michael’s responsibilities include the Malawi Major Overseas Programme, the Liverpool Centre for Research in Clinical Tropical Medicine, the Wellcome Trust Centre for Molecular Parasitology in Glasgow, the African Capacity Strengthening Strategic Awards, and the Public Health and Tropical Medicine Fellowship scheme.
Alison Wallace joined the Wellcome Trust in 2014 and contributes to developing and monitoring strategic funding initiatives in the infection and immuno-biology portfolio. Prior to this Alison held postdoctoral positions researching the maternal immune response to pregnancy, and obtained her PhD from the University of Edinburgh investigating the role of inflammation in cancer development. Alison has also worked on development of a vaccine against ovine chlamydia.
Senior Portfolio Developer
Marta Tufet contributes to the development and operation of the Trust’s International strategy, policy and scientific portfolio. Her responsibilities include, the African Institutions Initiative to strengthen research capacity in 51 African universities and research institutions, and the Joint DfID/MRC/Trust Global Health Trials Scheme to address major causes of mortality and morbidity in low and middle-income countries. Marta is a member of the Trust’s Challenge 3 team: Combating Infectious Disease. Previously she worked as a Science Portfolio Adviser, overseeing the Immunology portfolio, UK Biobank, the Kenya Major Overseas Programme, the Bloomsbury Centre for Clinical Tropical Medicine, and the Insect Pollinators Initiative. Prior to joining the Trust in 2009, she worked for Nature Reviews Immunology, and the Charles Darwin Foundation in the Galapagos Islands. Marta has a PhD in molecular parasitology (malaria) from Imperial College London. She speaks several languages having lived in Spain, Belgium, Portugal, France, Holland, and Ecuador.
International Operations Adviser
Alice Norton joined the Wellcome Trust at the beginning of 2009. She contributes to the operation and development of the strategy, policy and scientific portfolio of the Trust's international activities. She has particular responsibility for the African Institutions Initiative and the associated Learning and Evaluation Project. Other responsibilities include the WT/ Department of Biotechnology Indian Alliance Initiative and research capacity building projects in India and Africa. Previously Alice has been a member of the Trust’s Challenge 1 team: maximising the health benefits of genetics and genomics, and led on the Thailand and Vietnam Major Overseas Programmes.Before joining the Trust, Alice worked as Country Programme Manager for the Schistosomiasis Control Initiative in Tanzania. She has a BA in biological sciences from Oxford University, a PhD in parasitology from Imperial College London and postdoctoral experience in epidemiology, parasite population genetics and operational research in Kenya, Niger and Tanzania